United Therapeutics Corporation
Cash Flow Statement
| Line Item | FY2009 | FY2008 |
|---|---|---|
| Operating Activities | ||
| Net Income | $19.5M | $-49.3M |
| Depreciation & Amortization | $11.4M | $4.5M |
| Depreciation | $10.7M | — |
| Amortization | $717.0K | — |
| Stock-Based Compensation | $101.0M | $28.7M |
| Net Cash from Operating Activities | $99.7M | $-40.4M |
| Investing Activities | ||
| Capital Expenditures | $95.4M | $124.4M |
| Business Acquisitions | $3.6M | — |
| Net Cash from Investing Activities | $-162.6M | $-181.2M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $36.5M | $213.0M |
| Net Change in Cash | $-29.1M | $-9.9M |
| Free Cash Flow | $4.3M | $-164.8M |